Atlas Trials

Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study

Clinical trial NCT05614037 · UNKNOWN

Trial details

NCT number
NCT05614037
Sponsor
Overseas Pharmaceuticals, Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension
Start date
2022-10-28
Primary completion
2022-11-20
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.